Semaglutide, a glucagon-like peptide-1 receptor agonist, has been shown to reduce the risk of adverse cardiovascular events in patients with diabetes. Whether semaglutide can reduce cardiovascular ...

Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors. In this 1-year, multicenter, randomized, controlled trial, we ...

Last year Cummins in India crossed $1 billion in sales of which its automotive engine business alone accounted for over $260 million. This included contributions from Cummins Turbo Technologies ...